Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights
Provided By GlobeNewswire
Last update: Aug 11, 2025
SOMERSET, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its second quarter 2025 unaudited financial results and key corporate highlights.
Read more at globenewswire.com
